Evaluation of the anticoagulant effect of low-molecular-weight heparins based on the anti-Xa level during haemodialysis.

Mei TaoDanna ZhengXudong LiangMeiyu YeYueming LiuYiwen LiHuajuan ShenQiang He

Published in: Nephrology (Carlton, Vic.) (2020)

We found that over three haemodialysis sessions, no significant accumulation of LMWH was evident in subjects receiving a LMWH dose of between 2000 and 5000 IU for regular. Anti-Xa activity measurement can be used to adjust the dosage of LMWH and predict the anticoagulant effect during haemodialysis.

Keyphrases

end stage renal disease
peritoneal dialysis
atrial fibrillation
venous thromboembolism
chronic kidney disease